Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 2 , Pages 157-165, April 2010

Gastrointestinal and liver adverse effects of drugs used for treating IBD

  • Gerhard Rogler, MD, PhD, AGAF (Professor, Novartis Chair of Gastroenterology)

      Affiliations

    • Corresponding Author InformationTel.: +41 44 255 9477; fax: +41 44 255 9497.

Division of Gastroenterology and Hepatology, Department of Visceral Medicine, University Hospital Zürich, Rämistrasse 100, CH-8091 Zürich, Switzerland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6918(09)00159-0

doi:10.1016/j.bpg.2009.10.011

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 2 , Pages 157-165, April 2010

Article Tools